BMJ Open · 2013 · 104 citations · 33 references
Public HealthInternal MedicineClinical EpidemiologyHiv ControlHiv PreventionAntiretroviral TherapyHiv Care ContinuumHiv DiagnosisHiv EpidemiologyRetention In CareCd4 T-cell DepletionCohort Study InvestigationEarly Antiretroviral TherapyFollow-up ConsultationHiv MortalityIncidence RateOutcome MeasuresRetention In Hiv Care
OBJECTIVES: To describe loss to follow-up (LTFU) at all stages of the HIV programme. DESIGN: A retrospective cohort study. SETTING: The HIV clinic at Hospital National Simão Mendes in Bissau, Guinea-Bissau. PARTICIPANTS: A total of 4080 HIV-infected patients. OUTCOME MEASURES: Baseline characteristics, percentages and incidence rates of LTFU as well as LTFU risk factors at four different stages: immediately after HIV diagnosis (stage 1), after the first CD4 cell count and before a follow-up consultation (stage 2), after a follow-up consultation for patients not eligible for antiretroviral treatment (ART; stage 3) and LTFU among patients on ART (stage 4). RESULTS: Almost one-third of the patients were lost to the programme before the first consultation where ART initiation is decided; during the 7-year observation period, more than half of the patients had been lost to follow-up (overall incidence rate=51.1 patients lost per 100 person-years). Age below 30 years at inclusion was a risk factor for LTFU at all stages of the HIV programme. The biggest risk factors were body mass index <18.5 kg/m(2) (stage 1), male gender (stage 2), HIV-2 infection (stage 3) and CD4 cell count <200 cells/μL (stage 4). CONCLUSIONS: In this study, LTFU constituted a major problem, and this may apply to other similar ART facilities. More than half of the patients were lost to follow-up shortly after enrolment, possibly implying a high mortality. Thus, retention should be given a high priority.
33
Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1
Richard Marlink, Phyllis J. Kanki, Ibou Thior et al. · Science · 1994 · 626 citations
Enhanced CD4+ T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy
Tuan Le, Edwina Wright, Davey M. Smith et al. · New England Journal of Medicine · 2013 · 355 citations · Full text